SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 139 filers reported holding SERES THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,034,651 | -49.2% | 5,476,744 | +2.2% | 0.00% | -100.0% |
Q2 2023 | $25,660,906 | -22.7% | 5,357,183 | -8.5% | 0.00% | 0.0% |
Q1 2023 | $33,187,281 | -2.7% | 5,853,136 | -3.9% | 0.00% | 0.0% |
Q4 2022 | $34,120,448 | -19.6% | 6,092,937 | -7.8% | 0.00% | 0.0% |
Q3 2022 | $42,442,000 | +132.1% | 6,610,856 | +24.0% | 0.00% | 0.0% |
Q2 2022 | $18,285,000 | -49.3% | 5,330,817 | +5.2% | 0.00% | 0.0% |
Q1 2022 | $36,076,000 | -7.4% | 5,066,930 | +8.4% | 0.00% | 0.0% |
Q4 2021 | $38,953,000 | +41.5% | 4,676,265 | +18.2% | 0.00% | 0.0% |
Q3 2021 | $27,535,000 | -66.1% | 3,956,272 | +16.2% | 0.00% | -50.0% |
Q2 2021 | $81,223,000 | +15.4% | 3,405,570 | -0.4% | 0.00% | 0.0% |
Q1 2021 | $70,403,000 | -9.3% | 3,419,277 | +8.0% | 0.00% | 0.0% |
Q4 2020 | $77,599,000 | -0.5% | 3,167,319 | +15.0% | 0.00% | -33.3% |
Q3 2020 | $78,004,000 | +625.8% | 2,755,345 | +22.0% | 0.00% | – |
Q2 2020 | $10,748,000 | +39.7% | 2,257,979 | +4.8% | 0.00% | – |
Q1 2020 | $7,694,000 | +4.2% | 2,155,156 | +0.7% | 0.00% | – |
Q4 2019 | $7,382,000 | -12.0% | 2,139,641 | +2.3% | 0.00% | – |
Q3 2019 | $8,390,000 | +26.5% | 2,092,286 | +1.6% | 0.00% | – |
Q2 2019 | $6,635,000 | +7.2% | 2,060,327 | +128.7% | 0.00% | – |
Q1 2019 | $6,191,000 | +61.0% | 901,032 | +5.9% | 0.00% | – |
Q4 2018 | $3,846,000 | -50.8% | 850,846 | -17.4% | 0.00% | – |
Q3 2018 | $7,815,000 | -35.8% | 1,029,643 | -27.3% | 0.00% | -100.0% |
Q2 2018 | $12,180,000 | -3.3% | 1,416,254 | -17.5% | 0.00% | 0.0% |
Q1 2018 | $12,596,000 | -20.1% | 1,716,067 | +10.4% | 0.00% | 0.0% |
Q4 2017 | $15,762,000 | -40.9% | 1,554,567 | -6.5% | 0.00% | 0.0% |
Q3 2017 | $26,681,000 | +49.0% | 1,663,373 | +4.9% | 0.00% | 0.0% |
Q2 2017 | $17,911,000 | +1.5% | 1,585,026 | +1.2% | 0.00% | 0.0% |
Q1 2017 | $17,645,000 | +21.9% | 1,565,663 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $14,476,000 | -12.6% | 1,462,207 | +8.5% | 0.00% | 0.0% |
Q3 2016 | $16,558,000 | -51.6% | 1,347,194 | +14.5% | 0.00% | -50.0% |
Q2 2016 | $34,191,000 | +35.9% | 1,176,924 | +24.3% | 0.00% | 0.0% |
Q1 2016 | $25,151,000 | +31.6% | 946,954 | +73.8% | 0.00% | +100.0% |
Q4 2015 | $19,115,000 | +34.3% | 544,752 | +13.5% | 0.00% | 0.0% |
Q3 2015 | $14,232,000 | +1614.7% | 480,165 | +2300.8% | 0.00% | – |
Q2 2015 | $830,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 12,682,876 | $143,316,000 | 50.54% |
ARK Investment Management | 765,191 | $8,647,000 | 1.68% |
Rock Springs Capital Management LP | 220,000 | $2,486,000 | 0.13% |
Artal Group S.A. | 600,000 | $6,780,000 | 0.12% |
Virtus ETF Advisers LLC | 29,324 | $331,000 | 0.05% |
FEDERATED HERMES, INC. | 748,568 | $8,459,000 | 0.02% |
PDT Partners, LLC | 25,500 | $288,000 | 0.01% |
Baker Brothers Advisors | 125,000 | $1,413,000 | 0.01% |
D. E. Shaw & Co., Inc. | 527,261 | $5,958,000 | 0.01% |
FMR LLC | 6,056,294 | $68,436,000 | 0.01% |